Trifluoperazine PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Trifluoperazine PCD pharma franchise company in India, offering a focused range of 1 Trifluoperazine formulation manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antipsychotic products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Trifluoperazine?
Trifluoperazine is a phenothiazine typical antipsychotic that blocks dopamine D2 receptors to reduce psychotic symptoms. It is used in schizophrenia and, at lower doses, for short-term management of severe anxiety. Learn more from the PubChem compound record.
Available Trifluoperazine Formulations
Our current Trifluoperazine portfolio spans 1 Trifluoperazine formulation available in the following forms: Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Trifluoperazine is indicated for schizophrenia and short-term management of severe anxiety. It is prescribed by psychiatrists and mental health physicians and is dispensed strictly on prescription under qualified medical supervision.
Why Trifluoperazine is a High-Potential Molecule for Distributors
Typical antipsychotics remain cost-effective mainstays in public and private psychiatry, and trifluoperazine holds a steady institutional and retail demand base.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Trifluoperazine franchise business.
References
- PubChem: Trifluoperazine
- MedlinePlus: Trifluoperazine
- PubMed: Trifluoperazine research
Our formulations of Trifluoperazine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: